DJIA 16,397.37 134.81 0.83%
NASDAQ 4,072.40 38.24 0.95%
S&P 500 1,858.81 15.83 0.86%
market minute promo

50.10 0.49 (0.98%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

TEVA $50.10 0.98%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $50.04
Previous Close $49.61
Daily Range $50.02 - $50.52
52-Week Range $36.26 - $54.70
Market Cap $47.4B
P/E Ratio 33.30
Dividend (Yield) $1.17 (2.2%)
Ex-Dividend Date
Dividend Pay Date
02/20/14
03/10/14
Volume 4,016,049
Average Daily Volume 7,016,331
Current FY EPS $4.69

Sector

Healthcare

Industry

Drugs

Teva Pharmaceutical Industries (TEVA) Description

A global pharmaceutical company, Teva develops, produces, and markets generic drugs covering all major treatment categories. Website: http://www.tevapharm.com/

News & Commentary Rss Feed

Is This Drug Maker’s Stock Too Cheap to Ignore?

Teva Pharmaceutical shares have under performed its sector over the past year. Though the company faces a number of issues, most of the bad news may already be priced into the stock. Given the drug maker also appears to have some intriguing opportunities for future growth, are Teva shares too cheap to ignore?

Cramer's Lightning Round - I Was Too Bullish On LinkedIn (4/15/14)

Regulatory Update from Impax - Analyst Blog

Albany Molecular Aspires To Grow Revenue Five-Fold In As Many Years

Buy Actavis - An Attractive Value And Growth Play That Is Also A Top Guru Fund Pick

Teva to Launch Generic Lovaza - Analyst Blog

Teva Announces First Approval and Launch of Generic Lovaza® Capsules in the United States

Teva Pharmaceutical Industries Ltd (TEVA): Today's Featured Health Care Laggard

Why Teva Pharmaceuticals (TEVA) Stock Is Down Today

Eli Lilly Signs Deal with Prasco - Analyst Blog

The Medicines Co. Falls on Angiomax Woes - Analyst Blog

See More TEVA News...

TEVA's Top Competitors

TEVA $50.10 (0.98%)
Current stock: TEVA
JNJ $98.48 (-0.73%)
Current stock: JNJ
NVS $84.35 (0.67%)
Current stock: NVS
RHHBY $36.07 (-0.21%)
Current stock: RHHBY